2-[18F]-FDG PET/CT Role in Detecting Richter Transformation of Chronic Lymphocytic Leukemia and Predicting Overall Survival
2-[18F]-FDG PET/CT Role in Detecting Richter Transformation of Chronic Lymphocytic Leukemia and Predicting Overall Survival
复制标题
DOI:
10.1016/j.clml.2020.12.003
复制
发表时间:
2021-02-20
影响因子:
2.7
通讯作者:
Bertagna, Francesco
中科院分区:
文献类型:
--
作者:
Albano, Domenico;Camoni, Luca;Bertagna, Francesco
The present study investigated the potential value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (PET/CT) and its metabolic features for the detection of Richter syndrome (RS) and the impact on overall survival. All PET/CT metabolic parameters were significantly higher in RS compared with the no-RS group, except for metabolic tumor volume and total lesion glycolysis. Overall survival was significantly shorter in patients with RS than in patients without RS. Semiquantitative PET/CT parameters were independent prognostic factors.Introduction: Chronic lymphocytic leukemia (CLL) is an indolent, low-grade B-cell lymphoproliferative disorder, which may evolve into aggressive lymphoma, a phenomenon called Richter syndrome (RS). Our aim was to study the accuracy of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (2-[18F]-FDG PET/CT) and its semiquantitative parameters for the detection of RS and the impact on overall survival (OS). Materials and Methods: Eighty patients with histologically proven CLL were retrospectively included. PET/CT images were qualitatively and semiquantitatively examined by estimating the maximum standardized uptake value body weight (SUVbw), lean body mass (SUVIbm), body surface area (SUVbsa), lesion-to-blood-pool SUV ratio (L-BP SUV R), lesion-to-liver SUV ratio (L-L SUV R), total lesion glycolysis (TLG), and metabolic tumor volume (MN) and comparing them with the main clinical-histologic variables. OS curves were plotted according to the Kaplan-Meier method. Results: Seventy-eight patients had positive 2-[F-18]-FDG PET/CT, whereas the remaining 2 were not FDG-avid. All PET/CT metabolic parameters were significantly higher in the RS group compared with the no-RS group, except for MTV and TLG. The best thresholds identified were 9 for SUVbw, 5.3 for SUVIbm, 1.7 for SUVbsa, 2 for L-L SUV R, and 4.8 for L-BP SUV R. After a median follow-up of 32 months, 24 patients died; OS was significantly shorter in patients with RS than patients without RS (16.5 vs. 27.8 months; P = .001). Binet-stage, B symptoms, SUVbw, SUVIbm, SUVbsa, L-L SUV R, and L-BP SUV R were shown to be independent prognostic features. Conclusions: Semi-quantitative PET/CT parameters that are SUV-related may be useful in discriminating patients with a high risk of developing RS and also for predicting OS. (C) 2020 Elsevier Inc. All rights reserved.